Who is sponsoring NCT03530358?

NCT03530358 is sponsored by IRCCS San Camillo, Venezia, Italy.

What drugs are being tested in NCT03530358?

Interventions in NCT03530358: Technology-aided rehabilitation, Conventional rehabilitation.

What condition does NCT03530358 study?

NCT03530358 studies Stroke, Ischemic, Upper Limb Injury, Rehabilitation.

Is NCT03530358 still recruiting?

NCT03530358 is currently status unknown. Last updated 8 June 2022.

Last reviewed 2022-06-08 · How we verify

NCT03530358: MOSE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MOdularity for SEnsory Motor Control

Status unknown NA Last updated 8 June 2022

What this trial tests

NA trial testing Technology-aided rehabilitation in Stroke, Ischemic in 132 participants. Status unknown.

Timeline

1 December 2014

Primary endpoint
1 December 2018

1 December 2022

Quick facts

Lead sponsor	IRCCS San Camillo, Venezia, Italy
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	132
Start date	1 December 2014
Primary completion	1 December 2018
Estimated completion	1 December 2022
Sites	2 locations across Italy

Drugs / interventions tested

Technology-aided rehabilitation
Conventional rehabilitation

Conditions studied

Stroke, Ischemic — all drugs for Stroke, Ischemic →
Upper Limb Injury — all drugs for Upper Limb Injury →
Rehabilitation — all drugs for Rehabilitation →

Sponsor

IRCCS San Camillo, Venezia, Italy

Who can join

18 and older, any sex, with Stroke, Ischemic or Upper Limb Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

For this project the investigators ask, how the activation and organization of muscle synergies may be disrupted by brain lesions, and whether it is possible to modify synergy activations by means of specific therapies. Will be investigated whether there is a relationship between post-stroke cortical plasticity and changes in synergy activations due to a therapy.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

Effects of robot therapy on upper body kinematics and arm function in persons post stroke: a pilot randomized controlled trial.
Carpinella I, Lencioni T, Bowman T, Bertoni R, et al · · 2020 · cited 32× · PMID 32000790 · DOI 10.1186/s12984-020-0646-1
A randomized controlled trial on the effects induced by robot-assisted and usual-care rehabilitation on upper limb muscle synergies in post-stroke subjects.
Lencioni T, Fornia L, Bowman T, Marzegan A, et al · · 2021 · cited 31× · PMID 33674675 · DOI 10.1038/s41598-021-84536-8
Muscle Synergies and Clinical Outcome Measures Describe Different Factors of Upper Limb Motor Function in Stroke Survivors Undergoing Rehabilitation in a Virtual Reality Environment.
Maistrello L, Rimini D, Cheung VCK, Pregnolato G, et al · · 2021 · cited 16× · PMID 34884003 · DOI 10.3390/s21238002
Surface-Electromyography-Based Co-Contraction Index for Monitoring Upper Limb Improvements in Post-Stroke Rehabilitation: A Pilot Randomized Controlled Trial Secondary Analysis.
Bandini V, Carpinella I, Marzegan A, Jonsdottir J, et al · · 2023 · cited 12× · PMID 37687775 · DOI 10.3390/s23177320
Muscle Synergy Analysis for Clinical Characterization of Upper Limb Motor Recovery After Stroke.
Pregnolato G, Severini G, Maistrello L, Rimini D, et al · · 2026 · cited 3× · PMID 40484193 · DOI 10.1016/j.apmr.2025.05.019
Characterization of motor function recovery using muscle synergies in stroke patients undergoing upper limb rehabilitation
Pregnolato G, Severini G, Maistrello L, Rimini D, et al · · 2024 · DOI 10.1101/2024.09.24.24314287

Verify or expand the search:

Other recruiting trials for Stroke, Ischemic

Currently open trials in the same condition.

NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT06658197 — Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke · Phase 3 · recruiting
NCT07282041 — Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis · Phase 2, PHASE3 · recruiting
NCT07135089 — Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban · Phase 3 · recruiting
NCT07047014 — Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ische · Phase 3 · recruiting

Other IRCCS San Camillo, Venezia, Italy trials

Trials by the same sponsor.

NCT05956132 — Clinical and Biochemical Features for the Identification of Dominant Calpainopathies · unknown
NCT05934188 — Exploring the Gut-Brain Axis in Ageing and Neurodegeneration · recruiting
NCT06264037 — The Experience in Neurorehabilitation Setting: a Qualitative Study · unknown
NCT06270420 — Technological Devices and Home Automation System in Neurological Rehabilitation · NA · unknown
NCT05591040 — Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03530358 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IRCCS San Camillo, Venezia, Italy
Last refreshed: 8 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03530358.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing